Skip to main content
. 2018 Jan 30;18:26. doi: 10.1186/s12890-018-0589-5

Table 6.

Co-morbidities in COPD and non-COPD population

Ukraine Kazakhstan Azerbaijan
Non-COPDN = 909 COPDN = 30 p-valuea Non-COPDN = 882 COPDN = 63 p-valuea Non-COPDN = 898 COPDN = 35 p-valuea
Any co-morbidity 42.5% 56.7% 0.136 26.9% 50.8% < 0.001 53.8% 74.3% 0.023
Hypertension 14.0% 40.0% 0.001 25.5% 36.5% 0.074 16.8% 34.3% 0.012
Diabetes 3.4% 6.7% 0.621 3.4% 7.9% 0.078 5.2% 8.6% 0.428
Cardiovascular disease 6.0% 26.7% ˂0.001 7.8% 22.2% 0.001 3.5% 22.9% ˂0.001
Abnormal blood lipids 4.9% 13.3% 0.062 11.7% 15.9% 0.421 1.3% 0.0% 1.000
Depression 0.7% 0.0% 1.000 0.6% 0.0% 1.000 1.9% 2.9% 1.000
Anxiety 0.2% 0.0% 1.000 0.6% 0.0% 1.000 2.6% 5.7% 0.240
Osteoporosis 0.7% 0.0% 1.000 1.6% 3.2% 0.618 0.6% 0.0% 1.000
Tuberculosis 0.2% 6.7% 0.006 2.3% 0.0% 0.391 1.4% 2.9% 1.000
Pneumonia 19.4% 36.7% 0.024 14.9% 31.7% 0.001 5.9% 17.1% 0.019

atwo-sided Pearson Chi-Square test for a comparison between COPD and non-COPD populations

COPD population: respondents with COPD diagnosed by spirometry (post-dose FEV1/FVC < 0.70)

Non-COPD population: respondents without COPD diagnosed by spirometry (post-dose FEV1/FVC ≥ 0.70)